tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT

Pharmaxis Ltd (SNT) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
4Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Strong Sell
1Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Pharmaxis Ltd’s (SNT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pharmaxis Ltd is a Sell.
Pharmaxis Ltd’s (SNT) 20-Day exponential moving average is 0.02, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) 50-Day exponential moving average is 0.02, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.

Pharmaxis Ltd (SNT) Pivot Points

May 15, 2024, 06:27 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaxis Ltd (SNT) Moving Averages

May 15, 2024, 06:27 AM
Period
Simple
Exponential
MA5
0.02Buy
0.02Sell
MA10
0.02Buy
0.02Sell
MA20
0.02Buy
0.02Sell
MA50
0.02Sell
0.02Sell
MA100
0.02Sell
0.02Sell
MA200
0.03Sell
0.03Sell
Pharmaxis Ltd’s (SNT) 10-Day exponential moving average is 0.02, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) 100-Day exponential moving average is 0.02, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Sell.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 50-day simple moving average is 0.02, creating a Sell signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 100-day simple moving average is 0.02, creating a Sell signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 200-day simple moving average is 0.03, creating a Sell signal.

Pharmaxis Ltd (SNT) Technical Indicators

May 15, 2024, 06:27 AM
Name
Value
Implied Action
RSI (14)
40.58
Neutral
STOCH (9,6)
166.67
Sell
STOCHRSI (14)
150.00
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
25.65
Neutral
Williams %R
50.00
Sell
CCI (14)
159.42
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
100.00
Buy
ROC
0.00
-
Pharmaxis Ltd’s (SNT) Relative Strength Index (RSI) is 40.58, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Trend Strength Indicator (ADX) is 25.65, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Commodity Channel Index (CCI) is 159.42, creating a Sell signal.

FAQ

Is SNT a Buy, Hold, or Sell?
Based on SNT’s technical indicators, SNT is a Strong Sell.
    What is SNT’s RSI (14)?
    SNT’s RSI (14) is 40.58, which suggests SNT is a Neutral.
      What is SNT’s MACD?
      SNT’s MACD is >-0.01, which suggests SNT is a Sell.
        What is SNT’s 5-day moving average?
        SNT’s 5-day moving average is 0.02, which suggests SNT is a Buy.
          What is SNT’s 20-day moving average?
          SNT 20-day moving average is 0.02, which suggests SNT is a Buy.
            What is SNT’s 50-day moving average?
            SNT’s 50-day moving average is 0.02, which suggests SNT is a Sell.
              What is SNT’s 200-day moving average?
              SNT’s 200-day moving average is 0.03, which suggests SNT is a Sell.
                What is SNT’s Williams % R (14)?
                SNT’s Williams % R (14) is 50.00, which suggests SNT is a Sell.
                  What is SNT’s CCI (14)?
                  SNT’s CCI (14) is 159.42, which suggests SNT is a Sell.
                    What is the share price of Pharmaxis Ltd?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis